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Abstract  
Three biflavonoids [cupressuflavone (1), amentoflavone (2) and sumaflavone (3)], four 
diterpenoids [13-epi-cupressic acid (4), imbricatholic acid (5), 3-hydroxy-
sandaracopimaric acid (6) and dehydroabietic acid (7)] and one lignan [β-peltatin methyl 
ether (8)], were isolated from the cytotoxic fractions of the extracts of the leaves of the 
Libyan Juniperus phoenicea L. The structures of these compounds were elucidated by 
spectroscopic means. Cytotoxicity of the compounds 1-6 were assessed against the 
human lung cancer cell line A549 using the MTT assay. Compounds 1 and 3 showed 
cytotoxicity against the A549 cells (IC50 = 65 µM and 77 µM, respectively), whereas, 
compound 2 did not show any activity. Diterpenes 4-6 exhibited weak cytotoxicity 
against the A549 cells with the IC50 values of 159 µM, 263 µM and 223 µM, respectively. 
The cytotoxicity of each compound was compared with the anticancer drug, etoposide 
(IC50 = 61 µM). Cupressuflavone (1) was evaluated also for cytotoxicity against both the 
human PC3 cancer cell line and the normal prostate cell line (PNT2), and this compound 
revealed a high degree of cytotoxic selectivity towards the prostate cancer cells (PC3), 
with IC50 value of 19.9 µM, without any evidence of cytotoxicity towards the normal 
prostate cell line (PNT2). 
 
KEYWORDS: 
Juniperus phoenicea, Cupressaceae, cytotoxicity, biflavonoids, diterpenes, MTT assay  
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Key Points 
 Biflavonoids cupressuflavone (1) and sumaflavone (3) showed cytotoxic effect 
against the human cancer cell line A549. 
 Diterpenes 13-epi-cupressic acid (4), imbricatholic acid (5) and 3-hydroxy-
sandaracopimaric acid (6) were also cytotoxic to A549 cells. 
 Cupressuflavone (1) exhibited a high degree of cytotoxic selectivity towards the 
prostate cancer cells (PC3), compared to its cytotoxicity to the normal prostate 
cell line PNT2. 
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1 INTRODUCTION  
Juniperus phoenicea L. (Cupressaceae), commonly known as ‘Phoenician Juniper or Arâr’, 
is a well-known Libyan medicinal plant, which has been used in Libyan traditional 
medicine for the treatment of various human ailments including tumours and cancers (Al 
Groshi et al., 2018). Whilst previous phytochemical investigation on this plant revealed 
the presence of flavonoids, lignans, phenylpropanoids, sterols and terpenoids (Aljaiyash 
et al., 2014), bioactivity studies demonstrated its antidiabetic, antimicrobial, 
antiparasitic, contraceptive and cytotoxic properties (Sánchez de Medina et al., 1994; 
Qnais et al., 2005; Aljaiyash et al., 2014; Latif et al., 2014).  
The study conducted by Cairnes et al. (1980) revealed that the ethanolic extract of J. 
phoenicea twigs and leaves and two isolated compounds, desoxy-podophyllotoxin and β-
peltatin-methyl ether, were cytotoxic in KB cell cultures (human cervix carcinoma). A 
methanol (MeOH) extract of this plant from Saudi Arabia and Indonesia displayed 
cytotoxicity in Vero (normal monkey kidney) and HEP-2 (human laryngeal carcinoma) cell 
lines (Abdul et al., 2014). In addition, this plant also exhibited cytotoxicity against both 
MCF7 (human breast adenocarcinoma) and HCT-116 (human colon carcinoma) cell lines 
(Aljaiyash et al., 2014). The cytotoxicity of the n-hexane, dichloromethane (DCM) and 
MeOH extracts of the leaves of the Libyan J. phoenicea was evaluated against four 
human cancer cell lines: EJ138 (human bladder carcinoma), HepG2 (human liver 
hepatocellular carcinoma), A549 (human lung carcinoma), and MCF7 (Al Groshi et al., 
2018). The A549 appeared to be most sensitive to J. phoenicea extracts, with IC50 values 
of 16, 13 and 100 µg/mL for the n-hexane, DCM and MeOH extracts, respectively. As a 
part of our continuing cytotoxicity studies on this plant, we now report on the bioassay-
guided isolation of compounds from the active fractions of the extracts of the leaves of 
the Libyan J. phoenicea, and cytotoxicity of the isolated biflavonoids (1-3) and 
diterpenoids (4-6) against the human lung cancer cell line A549, and selective 
cytotoxicity of   cupressuflavone (1) against the human prostate cancer cell line PC3, 
compared to the normal prostate cell line (PNT2). 
5 
 
2 MATERIALS AND METHODS 
2.1 General experimental procedures 
Analytical HPLC was performed on a Dionex UPLC 3000 (Thermoscientific, UK) coupled 
with a photo-diode-array (PDA) detector (Thermoscientific). Extracts and fractions were 
analyzed on a Phenomenex C18 column (150 × 4.6 mm, 5 μm, Phenomenex, USA). An 
Agilent 1200 Infinity series preparative HPLC system coupled with a PDA detector 
(Agilent, UK) was used to isolate compounds, both at semi-preparative (Luna C18 semi-
preparative column, 150 × 10 mm, 5 μm) and preparative (Hichrom ACE C18 preparative 
column, 150 × 21.2 mm, 5 μm) scales. The column temperature was set at 25°C. The 
chromatogram was monitored at variable UV–vis wavelengths (205, 320 and 366 nm). 
NMR spectroscopic analyses were performed in CD3OD or DMSO-d6 solution on a Bruker 
AMX600 NMR spectrometer (600 MHz for 1H and 150 MHz for 13C) or Bruker AMX300 
NMR spectrometer (300 MHz for 1H and 75 MHz for 13C). ESIMS analyses were 
performed on a Xevo G2-S ASAP or LTQ Orbitrap XL1 spectrophotometer or on an Agilent 
6200 Series Accurate-Mass Time-of-Flight (TOF) LC/MS.  
 
2.2 Plant materials 
 Juniperus phoenicea L. was collected from Al-Jabal Al Akhdar, Libya, in June 2013. The 
plant material was identified at the Faculty of Science Herbarium, Tripoli-Libya, and a 
voucher specimen (no. D68122) was deposited there. Leaves of this plant were air-dried, 
ground and kept in a tightly closed amber coloured container for subsequent studies. 
 
2.3 Extraction 
Ground leaves of J. phoenicea (86.5 g) were subjected to Soxhlet extraction, sequentially, 
with n-hexane, DCM and MeOH (800 mL each). Ten cycles were employed for each 
extraction, and the heating mantle temperature for all extractions was kept constant at 
60°C. The extracts were filtered and evaporated to dryness using a rotary evaporator at a 
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temperature not exceeding 45°C under reduced pressure.  All extracts were preserved at 
4°C for further studies.  
 
2.4 Fractionation techniques 
The crude extracts of J. phoenicea leaves were separated into various fractions using 
vacuum liquid chromatography (VLC) on silica gel for the n-hexane and DCM extracts, 
and solid-phase extraction (SPE) on reversed-phase C18 silica for the MeOH extract 
(Sarker et al., 2005; Al Groshi et al., 2018). All resulting fractions were subjected to the 
MTT assay using human cancer cell lines (Al Groshi et al., 2018), and comprehensive 
chromatographic analyses were conducted on the cytotoxic fractions to isolate 
compounds 1-8.   
 
2.5 Isolation of compounds 
The active SPE fractions of the MeOH extract, fractions F3 (80% MeOH in water) and F4 
(100% MeOH), 50 mg each, were analyzed by semi-preparative reversed-phase HPLC 
(Agilent) (Sarker and Nahar, 2012), using the mobile phase gradient 30-100% 
MeOH/water, both solvents had 0.1% trifluoro acetic acid (TFA), for 30 min and held for 
10 min at 100% MeOH, 2 mL/min flow rate, monitored at 220, 254, 280 and 360 nm, to 
yield cupressuflavone (1, 12 mg, tR = 20.0 min), amentoflavone (2, 2.5 mg, tR = 21.9 min) 
and somaflavone (3, 1.5 mg, tR = 26.3 min). The active VLC fractions of the n-hexane 
extract, fractions F2-F5, were chromatographed separately over silica gel normal column 
chromatography, eluting with ethyl acetate in n-hexane (2%, 4%, 6%.....20% at 2% 
increment) to afford 13-epi-cupressic acid (4, 8.2 mg, Rf = 0.6). The active VLC fraction of 
the DCM extract, fraction F4 (130 mg), was subjected to prep-HPLC, employing a linear 
gradient elution, 50-100% acetonitrile/water, both solvents had 0.1% TFA, for 30 min 
and held at 100% acetonitrile for 10 min, to produce β-peltatin methyl ether (8, 0.5 mg, 
tR = 10.19), 13-epi-cupressic acid (4, 3.2 mg, tR = 14.12), imbricatolic acid (5, 10.3 mg, tR = 
15.56) and 3-hydroxy sandaracopimaric acid (6, 3 mg, tR = 17.5). Another active VLC 
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fraction of the DCM extract, fraction F6 (40 mg), was also analyzed by the same prep-
HPLC system to isolate  dehydroabietic acid (7, 1.3 mg, tR = 29.5).  
 
2.6 Isolated compounds 
2.5.1 Cupressuflavone (1)  UV (MeOH): λmax 204, 228, 274 and 330 nm; 1H NMR and 
13C NMR (600 MHz, DMSO-d6) and 13C NMR (75 MHz, DMSO-d6): Supplementary Tables 1 
and 2; ESIMS m/z 539 [M+H]+, suggested the molecular formula C30H18O10. All data were 
comparable to the published data (Alqasoumi et al., 2013).   
2.5.2 Amentoflavone (2). UV (MeOH): λmax 212, 270 and 332 nm; 1H NMR (600 MHz, 
CD3OD) and 13C NMR (150 MHz, CD3OD): Supplementary Tables 1 and 2; ESIMS m/z 539 
[M+H]+, corresponding to the molecular formula C30H18O10. All data were comparable to 
the published data (Markham et al., 1987; Terashima et al., 1999; Li et al., 2014; Bais &  
Abrol, 2016).                                               
2.5.3 Sumaflavone (3). UV (MeOH): λmax 224, 270  and 332 nm; 1H NMR (300 MHz, 
DMSO): Supplementary Table 1. ESIMS m/z 555 [M+H]+, corresponding to the molecular 
formula C30H18O11. All data were comparable to the published data (Markham et al., 
1987).                        
2.5.4 13-Epi-cupressic acid (4).  1H NMR (600 MHz, CDC13) and 13C NMR (150 MHz, 
CDC13): Supplementary Tables 3 and 4; ESIMS m/z: 319 [M-H]-, corresponding to the 
molecular formula C20H32O3. All data were comparable to the published data (Su et al., 
1994; Alqasoumi et al., 2013).                  
2.5.5 Imbricatolic acid (5). 1H NMR (600 MHz, CDC13) and 13C NMR (150 MHz, CDC13): 
Supplementary Tables 3 and 4; ESIMS m/z 321 [M-H]-, corresponding to the molecular 
formula C20H34O3. All data were comparable to the published data (Wenkert & 
Buckwalter, 1972; Su et al., 1994; Alqasoumi et al., 2013).                                                                                                
2.5.6 3-Hydroxy-sandaracopimaric acid (6). 1H NMR (600 MHz, CDC13) and 13C NMR 
(150 MHz, CDC13): Supplementary Tables 3 and 4; ESIMS m/z 317 [M-H]-, corresponding 
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to the molecular formula C20H30O3. All data were comparable to the published data 
(Kozo & Takami, 1972; Alqasoumi et al., 2013).    
2.5.7 Dehydroabietic acid (Callistrisic acid) (7). 1H NMR (600 MHz, CDC13): δH 7.18 (1H, 
d, J = 8.2, H-1`), 7.00 (1H, dd, J = 8.2, 1.7, H-2`), 6.89 (1H, brd s, H-4`), 2.89 (1H, dd, J= 
5.6, 16.6. H-7), 2.82 (2H, m, H-6`), 1.60 (2H, m, H-6), 1.27 (3H, s, H-12), 1.22 (6H, d, 
J = 7.0, H-7`, H-8`), 1.1 (3 H, s, H-13); 13C NMR (150 MHz, CDC13): δC 181.6 (C-19), 145.7 
(C-9), 145.4 (C-13), 135.0 (C-8), 126.8 (C-14), 125.4 (C-11), 124.0 (C-12), 52.8 (C-5), 43.8 
(C-4), 39.3 (C-3), 37.5 (C-1), 33.4 (C-15), 32.0 (C-7), 28.7 (C-18), 24.0 (C-6`,C-7`), 21.7 (C-
20), 20.9 (C-6), 19.9 (C-2). ESIMS m/z 301 [M+H]+, corresponding to the molecular 
formula C20H28O2. All data were comparable to the published data (Abad et al., 1991; 
Gonzáleza et al., 2010). 
2.5.8 β-Peltatin methyl ether (8). 1H NMR (600 MHz, CDC13): δH 6.36 (2H, s, H-2, H-6), 
6.28 (1H, s, H-3), 5.88 (2H, d, J = 5.9, O-CH2-O), 4.58 (1H, d, J = 4.3 Hz, H-7), 4.47 (1H, dd, 
J = 7.3, 1.3 Hz, H-9), 4.07 (3H, s, CH3O -6), 3.94 (1H, t, J = 9.6 Hz), 3.80 (3H, s, CH3O-4), 
3.76 (6H, s, CH3O-3, CH3O-5), 3.17 (1H, dd, J = 5.1, 16.8 Hz, H-7), 2.66 (1H, d, J = 4.5, H-
8`), 2.64 (1H, m, H-8), 2.45 (1H, dd, J = 10.6, 17.1 Hz, H-7); 13C NMR (150 MHz, CDC13): 
δc 175.5 (C-9′), 152.9  (C-3′, C-5′), 148.6 (C-4), 145.1 (C-6), 138.1 (C-1′, C-4′), 136.6 (C-5), 
132.0 (C-2), 121.3 (C-1), 108.7 (C-2′, C-6′), 104.8 (C-3), 101.3 (O-CH2-O), 72.8 (C-9), 59.7 
(CH3O-6), 56.7 (CH3O-3′, CH3O-5′), 55.7 (CH3O-4′) 47.7 (C-8′), 44.2 (C-7′), 32.7 (C-8), 27.9 
(C-7) . ESIMS m/z 429 [M+H]+, corresponding to the molecular formula C23H24O8. All data 
were comparable to the published data (Rojas-Sepúlveda et al., 2012).         
             
2.7 MTT assay 
The cytotoxic activity of the isolated compounds (1-6) from the active fractions of J. 
phoenicea leaves were assessed against the human lung carcinoma (A549) cell line. In 
addition, cupressuflavone 1 was assessed also for cytotoxicity against the human 
prostate cancer (PC3) cell line and the human prostate normal cell line (PNT2). The cells 
were cultured in RPMI-1640 medium supplemented with 10% foetal bovine serum and 
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seeded into 24-well plates (5 x 104 cells/well) and incubated under 5% CO2, 95% 
humidity at 37oC for 24 h. The different isolated compounds were dissolved in DMSO 
and then diluted in medium containing DMSO to achieve a range of concentrations of 
each compound, all with a final treatment concentration of DMSO of 0.01% (including 
the negative control). These doses of each compound were then used to treat the cells 
for 24 h before assessment using the MTT assay (Mosmann, 1983; Nemati et al., 2013).  
Briefly, each treatment dose was removed from the 24-well plates of cells and replaced 
with MTT solution (0.5 mg/mL MTT in medium 1 mL/well).  The cells were then 
incubated under 5% CO2, 95% humidity at 37oC for 2 h. The MTT solution was then 
removed from each well of cells and replaced with isopropanol (0.5 mL/well) to lyse the 
cells and release and solubilise the blue formazan product. Four samples (100 µL each) 
were taken from each well of the 24 wells of the assay plate and transferred to a 96-well 
plate. The absorbance of these samples was then measured at 570 nm on a Clario Star 
microplate reader. The average absorbance reading was calculated for each sample and 
was then expressed as a percentage of the mean value of the non-treated control 
absorbance readings on each occasion. The results for each treatment and dose are 
derived from at least 12 wells (n ≥12) from three or more separate occasions. 
 
2.8 Lactate dehydrogenase (LDH) assay 
The membrane integrity of cells in response to cupressoflavone (1) treatment was 
assessed by estimating the amount of LDH released into the culture media. The release 
of the cytosolic enzyme LDH into the medium is indicative of membrane damage and is 
often used as a measure of necrosis. The A549 cells were seeded at a density of (1× 105) 
cells/well in columns 1 to 9 of a 96-well plate (100 μL/well), while the columns 10 to 12 
were filled with complete medium without cells (100 μL/well) as a negative control. The 
cells were given 24h to adhere and start to proliferate. Then the cells in columns 1 to 3 
were treated with compound 1 at the concentration estimated to be its IC50 value (65 
μM) for 24h. Wells in columns 4 to 6 were untreated viable cells (low LDH release 
controls). After 24 h of treatment, a cell lysis buffer 10X (9% v/v Triton X-100 in distilled 
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H2O, 10 μL/well) was added to the medium in wells in columns 7 to 9 and incubated for 
15 min to allow complete lysis of the cells to occur (maximal LDH release controls). The 
LDH cytotoxicity detection kit (Roche) was used in accordance with the manufacturer's 
instructions by adding reaction mixture (1 mL lyophilized catalyst mixed with 11.25 mL of 
dye solution) into every well (100 μL/well) and incubated for a further 15 min at 37oC.  
After 15 min incubation, 50 μL/well stop solution (1M acetic acid), was added to each 
well of the 96-well plate (columns 1 to 12). The absorbance values were determined at 
two wavelengths, 490 nm and 690 nm and the 690 nm values were then subtracted from 
the 490 nm values.  The intensity of colour is proportional to LDH activity and therefore 
the amount of LDH released from cells. The necrotic percentage was expressed using the 
formula: (sample value/maximal release) × 100% (Chan et al., 2013).  
 
2.9 Statistical analysis 
All MTT assays were carried out in triplicate on separate occasions. One-way ANOVA of 
multiple comparisons was applied (between control and different concentrations) using 
Dunnett`s multiple comparison tests (GraphPad Prism version 7.04). The differences 
between groups were considered statistically non-significant (ns) at a P value ≥ 0.05, 
significant (*) at a P value < 0.05, very significant (**) at a P value < 0.01, highly 
significant (***) at a P value < 0.001. The results were mean values ± standard error of 
the mean derived from n ≥12 from three separate occasions.   
 
3 RESULTS AND DISCUSSION   
In this study, bioassay-guided fractionation was carried out on the J. phoenicea cytotoxic 
fractions of the leaves that were evaluated previously (Al Groshi et al., 2018).  The VLC 
fractions of the n-hexane extract, F2 to F5, and of the DCM extract, F4 and F6, and the 
SPE fractions of the MeOH extract, F3 and F4, were all considered cytotoxic. The most 
potent fraction appeared to be F5 of the n-hexane extract with an IC50 value of 10 
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µg/mL, then F4 of the DCM extract (IC50 value 19 µg/mL) and F3 and F4 of the MeOH 
extract (IC50 values 50 and 85 µg/mL) (Al-Groshi et al., 2018).  
Several phytochemicals, e.g., alkaloids, flavonoids, lignans, phenols, steroids and 
terpenes, possess cytotoxic properties against cancer cells (Fernando & Rupasinghe, 
2013). Notably, all these groups of phytochemicals have previously been isolated from 
the leaves and the berries of J. phoenicea and other Juniperus species grown in different 
countries (Cairnes et al., 1980; Comte et al., 1997; Barrero et al., 2004; Aboulela et al., 
2005).  
Biflavonoids comprise a group of dimeric flavonoids and possess different biological 
activities of high importance, such as anticancer, antioxidant, antimicrobial, 
antinociceptive and anti-inflammatory (Mercader & Pomilio, 2012). These compounds 
strongly affect the cancer cells with little effect on normal cell proliferation, suggesting a 
therapeutic potential against cancer (Mercader & Pomilio, 2012). Three biflavonoids, 
cupressoflavone (1), amentoflavone (2) and sumaflavone (3), were obtained from the 
active fractions (F3 and F4) of the MeOH extract of the leaves of J. phoenicea, and their 
structures (Figure 1) were elucidated based on spectral analyses (UV-Vis spectroscopy, 
NMR and MS spectrometry); all data were comparable to the respective published data. 
The three biflavonoids (1-3) were tested for cytotoxicity against the human lung cancer 
cell line A549. Here, compounds 1 and 3 were tested for the first time against this cell 
line; both showed moderate cytotoxicity against these cancer cells with the IC50 values of 
65 µM and 77 µM, respectively, and compared with the positive standard etoposide 
displaying an IC50 value of 61 µM (Table 1) whereas, compound 2 did not show any 
activity against these cancer cells. Compound 2 was previously reported as a weak 
cytotoxic agent against lung cancer cells A549. However, it was shown to possess potent 
cytotoxic effects against both MCF-7 and HeLa cells, with the IC50 values of 25 and 20 
μM, respectively (Lee et al., 2012).  
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Cupressoflavone (1) was previously reported from Juniperus turbinate (Venditti et al., 
2018), and it was shown to possess cytotoxic activity against the human cancer cell lines: 
breast adenocarcinoma  (MDA-MB 231), malignant melanoma (A375) and colon 
carcinoma (HCT116), with IC50 values of 16.1, 12.7 and 19.3 M, respectively, after 72 h 
incubation, using the MTT assay. However, on the present study compound 1 displayed a 
significant decrease in the percentage viability of lung cancer cells A549 at 
concentrations higher than 0.33 µM (Table 1). The LDH assay was also carried out on 
compound 1 against the lung cancer cell line (A549); the results suggested that 
cytotoxicity might result in cellular necrosis (Figure 2). The necrotic percentage was 
calculated as 56.3 %. As compound 1 was isolated in good amounts, and was the major 
compound among the active compounds, it was also tested on the prostate cancer cell 
line (PC3) and the normal prostate cells (PNT2). It is of interest that the prostate cancer 
cells (PC3) were more sensitive to compound 1 (IC50 = 19.9 µM) (Figure 3) than normal 
prostate cells (PNT2) (did not show any cytotoxicity) (Figure 4). 
In our study, sumaflavone (3) was isolated for the first time from J. phoenicea. However, 
it was previously reported from Rhus coriaria (Anacardiaceae) (Van Loo et al., 1988 and 
Selaginella tamariscina (Selaginellaceae) (Yang et al., 2006). Its effect on inducible nitric 
oxide synthase (iNOS) gene expression was studied and the results revealed both its 
inhibition on NO production and its blockage of the lipopolysaccharide (LPS)-induced 
expression of iNOS (Yang et al., 2006). Another study was carried out by Lee et al. (2008) 
and the results suggested that compound 3 could be developed as a potential preventive 
or therapeutic agent of skin aging by examining its effect on MMP-1 production and 
MMP-2 enzymatic activity in human dermal fibroblasts (HDFs) exposed to UV irradiation. 
MMPs are enzymes that are responsible for the degradation of ECM (extracellular 
matrix) components such as collagen and elastin.  
Our results revealed a highly significant cytotoxic effect of compound 3 against the A549 
cell line at the concentration of 135.3 µM, while the lower concentrations were found to 
be non-significant. The presence of the aromatic hydroxyl group at C-5 in 3 might have 
played a role in the potentiation of the cytotoxic activity, whereas, the lack of this 
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hydroxyl group in compound 2 might have had an inhibitory effect on this activity. It has 
previously been reported that the substitution of the aromatic hydroxyl group at C-5 in 
the A ring is essential for inhibition of cell growth of human promyelocytic leukaemia 
cells (HL-60) (Chen et al., 2014). 
There has been much research over the recent years highlighting the 
cytotoxic/anticancer activity of diterpenoids, either in vitro against a variety of 
mammalian cancer cell lines, or in vivo in animal models of cancer (Greay & Hammer, 
2015). However, lignans are secondary metabolites, which exhibited prominent 
cytotoxic, antioxidant and antitumor activities. Cairnes et al. (1980) showed that the 
ethanolic extract of J. phoenicea twigs and leaves in addition to two isolated 
compounds, desoxy-podophyllotoxin and β-peltatin-methyl ether, were cytotoxic to the 
KB cell cultures (human cervix carcinoma). 
The VLC fraction (F3) of the n-hexane extract and those (F4 and F6) of the DCM extract 
led to the isolation of four diterpenes (Figure 1). The 1H and 13C NMR spectroscopic data 
indicated that they could be two bicyclic diterpenes labdanes (13- epi-cupressic acid 4 
and imbricatolic acid 5), two tricyclic diterpenes (the pimarane 3-hydroxy 
sandaracopimaric acid 6 and the abietane dehydroabietic acid 7). The three diterpenes 
(4-6) were tested for their cytotoxicity against the A549 cell line and exhibited weak 
cytotoxicity with IC50 value of 159 µM, 223 µM and 263 µM, respectively (Table 1).  It has 
been suggested that compound 5 induces cell cycle arrest in the CaLu-6 cell line cell 
(human, Caucasian, lung, adenocarcinoma) (De Marino et al., 2011), but no cytotoxic 
effect of compound 6 on lung cancer cells has previously been reported.  
The VLC fraction F4 of the DCM extract also yeilded two lignans. The 1H and 13C NMR 
spectroscopic data indicated that they belong to the furan subgroups. The presence of 3, 
4, 5-trimethoxyphenyl, which are the most frequently occurring aromatic rings found in 
lignans (Tsopmoa et al., 2013), suggesting that they are deoxypdophyllotoxin and β-
peltatin methyl ether 8 (Figure 1). Deoxypdophyllotoxin was impure, but its presence in 
F4 with the other lignan 8 indicates the high potency of this fraction (IC50 = 19 g/mL). 
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Deoxypodophyllotoxin mixture was also tested against A549 and it showed potent 
cytotoxicity with an IC50 value of 1.11 g/mL. The reference anticancer drug, etoposide 
was cytotoxic against the A549 lung cancer cells in this study at IC50 value = 61 µM. 
 
CONCLUSIONS  
The outcome of this study suggested that the cytotoxicity observed with the less polar 
extracts and fractions of J. phoenicea leaves was contributed by various cytotoxic lignans 
and terpenes, while the cytotoxic activity revealed in the more polar MeOH extract and 
fractions was due to the presence of cytotoxic biflavonoids. Cupressoflavone 1 revealed 
a high degree of selectivity against prostate cancer cells, which might suggest that this 
compound could be an ideal candidate for further studies towards developing it as a 
potential anticancer therapeutic agent. 
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                  Figure 1: Isolated compounds from the Libyan J. phoenicea leaves 
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Figure 2: LDH release result for cupressuflavone (1) against the lung cancer cell line 
(A549) 
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Figure 3: The cytotoxic activity of cupressoflavone (1) against prostate cancer cell 
line (PC3) and the human prostate cell line (PNT2) 
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Table 1:  The IC50 (µM) of different isolated compounds from J. phoenicea leaves on A549 
lung cancer cells. 
Pure compound IC50 µM ± S.E 
Cupressoflavone (1) 65 ± 1.55 
Amentoflavone (2) No activity 
Sumaflavone (3) 77 ± 1.64 
13-Epi-cupressic acid (4) 159 ± 1.16 
Imbricatolic acid (5)  263 ± 2.45 
3-Hydroxy-sandaracopimaric acid  (6)  223 ± 2.47 
Etoposide  61 ± 1.56 
 
 
 
